PATENT CLAIM ANALYSIS

Application Number: 15898545
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "397000"]

Abstract:
Methods for treating cancer include administering and/or receiving, at a patient in need thereof, a therapeutic dose of an inhibitor of extracellular vesicle signaling. The methods can additionally include co-administering and/or additionally receiving, at the patient in need thereof, a therapeutic dose or regimen of chemotherapy. In some instances, the cancer includes solid tumor carcinomas such as, but not limited to, colorectal cancer, pancreatic cancer, breast cancer, lung cancer, and prostate cancer. The disclosed treatment methods can act to suppress one or more of tumor growth, resistance to drug therapy, evasion of apoptosis, and/or metastasis.

Claim (Index 5):
The method of  claim 2 , wherein the inhibitor of extracellular vesicle signaling comprises GW4869.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 88.0
- Lexical Diversity: 1.73846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14760510', '14480098', '15545937', '14706038', '15630024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7802898311268541
- 35 USC 102 Novelty (BERT): 0.5098399780791333
- Combined Prediction Score: 0.7532448458220821
- Mean Citation Score: 250.490584
- Max Citation Score: 255.95547
- Similarity Product: 167.6480183982396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test